Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
In oncogenic osteomalacia (OOM), fibroblast growth factor 23 (FGF23) induces renal phosphate wasting and inhibits the appropriate increase of calcitriol. A patient suffering from OOM is described. Serum calcium, phosphate, biointact parathyroid hormone and intact FGF23 as well as the calcitriol and...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400509/ |